Post My Press Release

Free Press Release Distribution

Category: Biotechnology (Page 1 of 61)

Global Irritable Bowel Syndrome Treatment Market with present Situation and Forecast To 2026

The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life. However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.

Some major players operating in the irritable bowel syndrome treatment market are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.

Request Sample Copy Of This Research Report:

https://www.coherentmarketinsights.com/insight/request-sample/506

Market Dynamics

The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.

Market Taxonomy

This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.

Key features of the study:

This report provides in-depth analysis of irritable bowel syndrome treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global irritable bowel syndrome treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Abbott Laboratories*, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., Ironwood Pharmaceuticals, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the Irritable Bowel Syndrome Treatment Market

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/506

Detailed Segmentation:

Global Irritable Bowel Syndrome Treatment Market, By Drug Type:

Lubiprostone

Linaclotide

Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:

IBS-Constipation

IBS-Diarrhea

Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:

Hospital Pharmacies

Global Irritable Bowel Syndrome Treatment Market, By Geography:

North America

Europe

Asia-Pacific

Latin America

Middle East

Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

Textile Chemicals Market Size, Share, Revenue Sales, Dynamic Demand Research, Growth Trends, Business Opportunities Regional Outlook to 2022

Textile Chemicals Market Key Players:

Sumitomo Chemicals Co., Ltd., AkzoNobel, Arkema, Kiri Industries, Lubrizol, BASF SE, Bayer AG, Dow Chemical Company, Huntsman International LLC, Omnova Solutions, Pulcra Chemicals, and Sumitomo Chemical among others are some of the prominent manufacturers in the competitive scenarios of Global Textile Chemicals Market and are profiled in MRFR Analysis.

Textile Chemicals Market surged to USD 9.80 Mn in 2017, the market will expand at CAGR of over 3.2% over the forecast period (2018-2022).

Visit for Sample Report @ https://www.marketresearchfuture.com/sample_request/2063

Textile Chemicals Market Regional Analysis:

Geographically, Asia Pacific accounted for the leading market share for textile chemicals in 2016, followed by North America which is further trailed by Europe. In North America the Textile Chemicals market is expected to exhibit moderate growth over the assessment period due to substantial growth of textile industry in this region. Asia Pacific is expected to witness tremendous growth over the forecast period in textile chemicals market on account of increasing application of textile chemicals in various end use applications. In Asia Pacific, the demand for textile chemicals is estimated to enhance in several countries such as South Korea, Taiwan, India, Japan, Indonesia, China, and the Philippines due to improving population combined with shifting of manufacturing facilities for most of the matured market players in this region.

In Europe, textile chemicals market is anticipated to register above average growth owing to shifting consumer preference towards the textile chemicals-based products along with high adoption rate in various application segment specifically in Spain, France, Italy, Germany, Poland, Belgium, UK, and Russia. In addition, numerous countries of Latin America and the Middle East & Africa are estimated to witness moderate growth in textile chemicals owing to increasing disposable income combined with sales of textile chemicals-based product specifically in Mexico, Chile, Brazil, Guatemala, Argentina, Peru, and Venezuela along with expanding textile sector specifically in UAE, Qatar, Kuwait, Oman, Israel, Saudi Arabia, and Turkey.

Textile Chemicals Market Segmentation:

By application, the market is segmented into home furnishings, apparel, industrial textiles, and technical textiles. Increasing expenditure on home furnishings helps propel the textile chemicals market. Textile chemicals are used for carpets, rugs, furniture, and much more. Also, the rise in per capita spending on apparel has proved to be positive for the textile chemicals market.

If You Have Query, Inquire @  https://www.marketresearchfuture.com/check-discount/2063

Industry/ Innovation/ Related News:

January 2018- Kemin Industries announced to acquire Garmon Chemicals, a leading producer of textile chemicals and auxiliaries. This strategic move will help Garmon to expand their research and development operations.

November 2016- Huntsman Corporation announced that its Singapore based division signed an agreement with China based Jihua Group to manufacture dyes and intermediates to meet the demand for chemical solutions across the globe. 

August 2016- TANATEX Chemicals, a leading provider of specialty textile chemicals announced to merge with Transfer Chemicals. With this merger Transfer Chemicals will utilize TANTEX Chemical’s global footprint to accelerate growth.

May 2016- DyStar Global Holdings establishes an agreement with Emerald Performance Materials to acquire five specialist chemicals units. This acquisition will help company to expand company’s growth and reach within the textile chemicals market.

July 2015- Archroma, a Swiss based organization announced to complete their merger with BASF’s global textile chemicals. With this agreement BASF will produce and provide textile chemicals products to Archroma India under a long-term agreement. This acquisition will help company to strengthen Archroma’s position as an industry leader in supplying chemicals and dyes to global textile industry.

Textile Chemicals Market Table of Content:

1 Executive Summary

2 Scope of The Report

3 Market Research Methodology

4 Market Landscape

5 Industry Overview of Global Textile Chemicals Market

Textile Chemicals Market Table of Content to be Continue…….,

Read Report Overview @ https://www.marketresearchfuture.com/reports/textile-chemicals-market-2063

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bakery Release Agents Market Expected to Reach US$ 597.3 Mn by 2026

According to a new market report published by Transparency Market Research titled “Bakery Release Agents Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026,” the global bakery release agents market is expected to reach a value of US$ 597.3Mn by 2026. In terms of value, the market is estimated to expand at a CAGR of 5.2% during the forecast period from 2018 to 2026. In terms of volume, the market stood at around 630.4 thousand tons in 2017. The North American bakery release agents market is projected to have the highest growth during the forecast period.The market witnessed considerable growth due to increased demand for bakery products by manufacturers, supported by the population demand.

Request a Sample of Bakery Release Agents Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48615

The bakery release agents market is growing primarily due to the increased consumption of bakery products supported by the ever increasing population in developing countries. Out of the global network of release agents, the U.S. stands at first position in terms of demand for these products. The demand for bakery release agents in the U.S. and other countries are influenced by the rise in consumption of bread. Bread being the highest consumed bakery product, has the largest application of bakery release agents. On the other hand, one of the main challenging factors affecting this industry is the cost of ingredients such as vegetable oils. However, the bakery release agents market is expected to overcome this challenge by the use of cost effective organic ingredients.

In 2017, based on form of these agents, the liquid segment accounted for market value of about US$ 184.9 Mn in the global bakery release agents market. Liquid bakery release agents are widely manufactured and consumed globally due to its properties that result in a smooth texture of the products, and easy application. In terms of product type, globally the pastries segment is expected to expand at the highest CAGR of about 5.4% in terms of value, followed by bread which accounted for the largest market share. Bread being the highest consumed bakery product, has the largest application of bakery release agents. The use of a low-viscosity, high-performance release agent is generally recommended for these baked products.These factors are expected to showcase growth potential for bakery release agents in bread. In terms of ingredients, the vegetable oil segment is anticipated to account for the largest market share in terms of value. Vegetable oils affect the polymerization/ resinification and oxidation stability in bakery product processing. Vegetable oils such as soybean oil, palm oil, and others are widely used by bakery products manufacturers. This factor is primarily responsible for the major share of vegetable oils in the bakery release agents market. Furthermore, in terms of end-use, the industrial and commercial segment is anticipated to account for the largest share and is expanding at a higher CAGR than the residential segment.The industrial utility of bakery release agents is categorized by various products such as baked goods, biscuits, and breakfast cereals. By geography, North America region is expected to continue its dominance in the bakery release agents market with more than 35% market share in 2017. Across North America, the U.S held 41% market share in the bakery release agents market in the year 2017.

Get Table of Content @ https://www.transparencymarketresearch.com/report-toc/48615

The top companies considered while studying this report for the global bakery release agents market are Archer Daniels Midland Company, Mallet & Company, Inc., Masterol Foods Pty. Ltd., Cargill, AAK AB, Avatar Corporation, Sonneveld Group B.V., British Bakels Ltd., Lasenor Emul, S.L., and Maverik Oils, L.L.C.

Global Industrial Microbiology Market Present Chances, Trends, Value Chain And Stakeholder Analysis 2018-2026

Applied Microbiology involves use of microorganisms in various industries, such as pharmaceutical and biotechnology industry, cosmetic industry, food and beverages industry, agriculture and environment, and many others. The use of advanced technology and knowledge about microorganisms in healthcare and environmental issues is of prime importance. In case of pharmaceutical industry the products manufactured using microbiology include amino acids, organic acids, vitamins, nucleotides, antibiotics, insulin and other hormones, polysaccharides, bio surfactants, and hormones. Pharmaceutical microbiological safety, food microbiological safety, cosmetics microbiological safety and contamination control can be assured with the application of microbiology. Application of microorganisms is beneficial as maximum yield of a product can be obtained with the help of customization of the microorganism species such as exposing them to mutagens or by gene amplification. Biomass conversion is another area wherein microorganisms are employed in various processes such as anaerobic digestion, fermentation, pyrolysis, and gasification.

Some major players operating in the industrial microbiology market include:

Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Eppendorf AG, Bruker, Sartorius AG, QIAGEN, Becton Dickinson and Company, Bio-Rad Laboratories Inc., and Mettler-Toledo International Inc.

Request Sample Copy of This Research Report:

www.coherentmarketinsights.com/insight/request-sample/981

Quality control in pharmaceutical and food industry is of paramount importance, as healthcare is directly associated with the products from these industries. Microbial contamination in injectable, eye drops, drugs, nasal solutions, and food industries can be prevented with the help of micro-organisms by using various tests such as bio burden and growth promotion tests. According to the World Health Organization (WHO), unsafe food contaminated with harmful bacteria, parasites, and viruses can cause more than 200 diseases from diarrhea to cancers. Furthermore, food contamination has cost around 33 Mn of healthy life years according to the WHO. Microorganisms offer properties, such as rapid multiplication and growth rate, biodiversity, great shelf life, and use of byproducts after microbial process is finished, which saves time and cost for various industries. The field has advanced over years with inventions, such as microscope and increasing knowledge about microbial genetic makeup and biological processes associated with microorganisms.

Some of the lucrative areas for application of microbiology include bioremediation, bio-fuels production, genetic engineering, green chemistry, and metabolic engineering over the forecast period. Natural fuel consumption has increased exponentially over the past few years, owing to lifestyle changes, increased number of vehicles, and natural fuel resources, which are depleting at faster rates. Wherein bio-fuels can be a remedy. Genetically modified food products can also be an effective remedy against malnutrition in emerging economies such as Africa. Microorganisms are used in biotechnology field, especially in Recombinant DNA technology for various applications, such as crop agriculture, gene therapy, pharmaceutics, vaccine design and bioremediation, and further advancement in the respective areas is expected to boost the market growth over the forecast period.

Key features of the study:

This report provides in-depth analysis of Industrial Microbiology Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading player.s

It profiles leading players in the global Industrial Microbiology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.

Detailed Segmentation:

Global Industrial Microbiology Market, By Product Type:

Equipments and Systems

Reaction Consumables

Laboratory Supplies

Global Industrial Microbiology Market, By End User:

Pharmaceutical and Biotechnology Industry

Food and Beverages Industry

Cosmetic Industry

Agriculture and Environment

Others

Download the PDF brochure:

www.coherentmarketinsights.com/insight/request-pdf/981

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr.Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

Visit our news Website: www.coherentwire.com

Interspinous Process Decompression Devices Market Necessity And Demand 2018 to 2026

Interspinous process decompression device also called as interspinous spacer are medical implants used for treatment of spinal stenosis. This devices are intended to reduce the spinal pain via positioning between the vertebrae through minimally invasive surgical procedures. Interspinous process decompression device are one of the types of dynamic stabilization devices used for non-fusion spinal surgery, designed to be permanently implanted between two interspinous processes in lower spine without attaching screws or hardware to the bone or ligaments.


Interspinous Process Decompression Devices Market – Drivers

Since recent past, minimally invasive surgical procedures have gained traction resulting in development of various interspinous process decompression device. The global interspinous process decompression device market is expected to be driven by the new product launches by the market players. For instance, in 2015, Vertiflex, Inc., innovator in minimally invasive intervention for spinal stenosis, received Premarket Approval Application (PMA) order from the U.S. Food and Drug Administration (FDA) for its product, Superion, indicated for moderate lumbar spinal stenosis. The Superion is least invasive motion preserving device in interspinous spacers’ category. In 2015, the implant was successfully implanted in 2,000 patients around the world as a part of study and is expected to be available in the US market during the forecast period.

Moreover, in 2014, Exatech launched Octane Elevate, a new lumbar spacer to restore disc height and addressing anatomical conditions. In 2012, Paradigm Spine’s Coflex (previously called Interspinous U) Interlaminar Technology implant was approved by the FDA through the premarket approval process for one- or two-level lumbar stenosis from L1 to L5 producing at least moderate impairment in skeletally mature patients. Moreover, according to Permera Blue cross, the US-based medical insurance company, NL-Prow (by Non-Linear Technologies), Aperius (by Medtronic plc.), and Falena (by Mikai) devices are in trials in Europe.

Increasing incidence of spinal injuries is also expected to boost growth of interspinous process decompression devices market. According to the National Center for Biotechnology Information (NCBI), in 2007, the global incidence of spinal cord injury was estimated to be 170,312 cases, which increased up to 250,000 to 500,000 cases in 2013. Moreover, reimbursement policies are expected to fuel growth of the interspinous process decompression device market. For instance, in 2016, the International Society for the Advancement of Spine Surgery (ISASS) published recommendations and coverage criteria for decompression with interlaminar stabilization. However, lack of national coverage determination handover the policy discretion to local Medicare carriers.


Interspinous Process Decompression Devices Market – Taxonomy

By Product Type

  • X-STOP
  • DIAM
  • Coflex
  • Wallis
  • Others

By Flexibility

  • Compressible
  • Non-compressible

By End User

  • Hospital
  • Ambulatory Surgical Centers

Interspinous Process Decompression Devices Market – Competitor

Abbott Spine, Paradigm spine, Medtronic Plc. and Vertiflex, Inc. are the key players implementing novel inorganic strategies for gaining maximum market shares, in turn strengthening market position.


Ask For Sample Copy Of This Business Research Report : 
https://www.coherentmarketinsights.com/insight/request-sample/2316


Interspinous Process Decompression Devices Market – Regional Analysis

Based on geography, the interspinous process decompression devices market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. The North American interspinous process decompression device market holds a dominant position attributed to increasing adoption rate for new technologies. Furthermore, Asia Pacific is expected to witness fast growth during forecast period, owing to increasing medical facilities and increasing geriatric pool. For instance, according to Economic and Social Commission for Asia and the Pacific, 2016, between 2015 and 2030, number of people aged 60 years or older are projected to increase in Asia by 66%.


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Viral Vector Manufacturing Market

Viral Vector Manufacturing Industry by Disease, Types, Application Research Insights 2018 to 2023

Global viral vector manufacturing market is expected to grow significantly over the forecast period. It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period of 2018–2023.

Gene therapy is one of the preferred treatment options for most chronic diseases, involving insertion of a functional copy of a gene into a defective cell. Viral vector methods are used in effective transfer of therapeutic gene into the target cells. Viral vectors used in gene therapy include retroviral vectors, adenoviral vectors and adeno-associated viral vectors.

Numerous factors such as rise in number of clinical trials, increase in the number of gene therapy candidates, and growing necessity for an effective mode of disease treatment are expected to drive the growth of the market. Also, the characteristics of viral vectors such as ability to express therapeutic genes efficiently, and non-pathogenic nature fuels the growth of the market.

Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/6890

Key players:

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., and Kaneka Eurogentec S.A. are some of the key players in the global viral vector manufacturing market.

Segmentation:

The global viral vector manufacturing market has been segmented into type, disease, application, and end-user.

Global Viral Vector Manufacturing Market, by Type

  • Retroviral Vectors
    • Lentiviral Vectors
    • Gamma-Retroviral Vectors
  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
  • Other Viral Vectors

Global Viral Vector Manufacturing Market, by Disease

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

Global Viral Vector Manufacturing Market, by Application

  • Gene Therapy
  • Vaccinology

Global Viral Vector Manufacturing Market, by End-user

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Browse Complete Report Details at https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global viral vector manufacturing market owing to a well-developed healthcare sector and rising prevalence of autoimmune and chronic diseases. According to a study published by Partnership to Fight Chronic Disease (PFCD) in 2016, 191 million people in America had at least 1 chronic disease, whereas 75 million had 2 or more chronic diseases in the year 2015.

Europe is expected to hold the second largest position in the global viral vector manufacturing market. The market growth in this region is attributed to the availability of funds for research and increasing healthcare expenditure. According to the European Commission, in 2016 the total expenditure of the governments of the European Union on health amounted to 7.1% of GDP. Also, according to National Institute of Health Funding (NIHR) in the year 2016, a funding of Euro 928 million was announced for new NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities (CRF) for 5 years starting from April 2017.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.

On the other hand, the Middle East and Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6890

Intended Audience

  • Pharmaceutical Companies
  • Research and Development (R&D) Companies
  • Private Research institutes
  • Diagnostic Laboratories
  • Government Research Institutes
  • Academic Institutes and Universities

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Stereotactic Surgery Devices Market

Stereotactic Surgery Devices Market Comprehensive Insights and Trend Report 2019

Global Stereotactic Surgery Devices Market held a market value of USD 16.59 billion in the year 2017 and is expected to grow at a CAGR of 5.2% during the forecast period. Stereotactic surgery is a minimally invasive form of surgical intervention that uses a 3D coordinate system to locate small targets inside the body and perform actions such as ablation and biopsy.

The rising preference for minimally invasive surgeries, increasing adoption of stereo static surgery devices, and growing prevalence of brain-related diseases such as Parkinson’s disease, brain tumor, and others is anticipated to drive the growth of the market over the assessment period.

Global Stereotactic Surgery Devices Market, by Key Players

  • Koninklijke Philips N.V.
  • Huiheng Medical, Inc.
  • Mitsubishi Heavy Industries, Ltd.
  • GE Healthcare
  • Varian Medical Systems
  • Hitachi Medical Systems
  • Accuray, Inc.
  • Ferring B. V.
  • Shinva Medical Instrument Co., Ltd
  • Elekta AB

Get Sample Research Report at https://www.marketresearchfuture.com/sample_request/6791

Segmentation:

The global stereotactic surgery devices market has been segmented into product type and application.

The global market, on the basis of product type, has been segmented into gamma knife, Linear accelerators (LINAC), proton beam therapy, and cyberknife. By product type, linear accelerators (LINAC) segment is expected to hold largest market share owing to the growing adoption rate and installations. Additionally, cyberknife is expected to be the fastest growing segment over the assessment period owing to its growing popularity in the developing economies.

On the basis of application, the market has been segmented into brain tumor, arteriovenous malformations, Parkinson’s disease, epilepsy, and others.

On the other hand, the high installation cost and low treatment charges delays the recovery of the invested amount which thus limits the adoption of the technology. This factor is expected to hamper the growth of the market over the forecast period.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Stereotactic Surgery Devices Market, By Product Product Type

6.1 Introduction

6.2 Gamma Knife

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3 Linear Accelerators (LINAC)

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.4 Proton Beam Therapy

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.5 Cyberknife

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

Chapter 7. Global Stereotactic Surgery Devices Market, By Application

7.1 Introduction

7.2 Brain Tumor

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.3 Arteriovenous Malformations

Market Estimates & Forecast, By Region, 2018–2023

… Continue

Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/stereotactic-surgery-devices-market-6791

Regional Analysis:

Geographically, the Americas is expected to dominate the global market owing to the rising prevalence of neurological diseases, presence of developed healthcare infrastructure, and high disposable income. Europe is anticipated to hold the second largest position in the global stereotactic surgery devices market. The market growth in this region is mainly due to the increasing occurrences of brain diseases and presence of developed healthcare sector. The Asia-Pacific region is expected to be fastest growing region owing to the growing prevalence of brain-related diseases and continuously growing healthcare sector. The Middle East & Africa has the least share of the market owing to the limited presence of developed healthcare infrastructure in the African region.

According to the National Tumor Society, an estimated 700,000 people in the US were living with a primary brain tumor in 2017 and about 78,980 people are expected to be diagnosed for primary brain tumor in 2018. Moreover, according to reports published by Elekta AB company, an estimated 70,000 patients undergo gamma knife surgery each year.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Embolization Particle Market Size, Share, Outlook, and Opportunity Analysis, 2018–2026

Embolization is a minimally invasive therapy in which an embolus is injected to stop bleeding or to cut off the supply of blood to a tumor in order to shrink it for preparation of its removal. Embolization is used in various interventional radiology procedures. In this procedure, an interventional radiologist uses image guidance to insert the catheter into a primary artery and advance it to vessel leading to a tumor or other part where the blood supply needs to be blocked. Embolization is an option for some patients with tumors that cannot be removed by surgery. It can be used for tumors that are usually larger than 5 cm thickness and cannot be removed by ablation. This procedure is used to treat various types of cancerous tumors, hemorrhages, along with the management of malignant hypertension caused by renal failure.


Download PDF Brochure of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-pdf/2374

Embolization Particle Market – Market Dynamics

Embolization particles are the crucial product used in the treatment of malignancies such as cancer, peripheral diseases, and others. Rising prevalence of cancer globally, has supported growth of the embolization particle market. According to World Health Organization (WHO), cancer is the second prominent cause of death across the globe, and around 9.6 million deaths occurred due to cancer in 2018. Moreover, as per the Cancer Research UK, over 17 million new cases were estimated to occur in year 2018 around the globe. The burden of cancer is increasing rapidly in the U.S. with the incidence of 439.2 per 100,000 men and women per year as according to National Cancer Institute (2015).

Moreover, major players are constantly introducing technologically advanced products with improved efficiency that supports growth of the embolization particle market. For instance, in 2017, Sirtex introduced SIR-Spheres Y-90 resin microspheres, which serves as first-line treatment for patients with liver metastases from right-sided primary colon cancer. In 2016, UK National Institute for Health and Care Excellence (NICE) issued a new update stating that National Health Service (NHS) doctors and commissioners may consider Sirtex’s SIR-Spheres Y-90 resin microspheres as an alternative to standard therapy with trans-arterial chemoembolization (TACE) or sorafenib in the treatment of patients with inoperable primary liver cancer.


Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/2374


Embolization Particle Market Taxonomy

On the basis of product type, the global embolization particle market is segmented into:

  • Radioembolization Spheres
  • Microspheres
  • Drug Eluting Beads
  • PVA Particles & Gelfoam Particles
  • Other Particles

On the basis of application, the global embolization particle market is segmented into:

  • Peripheral Vascular Disease
  • Neurology
  • Oncology
  • Urology
  • Others

On the basis of end-user, the global embolization particle market is segmented into:

  • Hospitals & Clinics
  • Ambulatory Centers
  • Others

On the basis of treatment, the global embolization particle market is segmented into:

  • Urethral Dilation
  • Direct Vision Internal Urethrotomy (DVIU)
  • Urethroplasty
  • Others


Embolization Particle Market – Regional Insights

On the basis of geography, the global embolization particle market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America would be dominant region in the global embolization particle market in 2017. This is owing to the strong economic condition, huge expansion of healthcare domain, and increasing focus of research institutions on modernizing technology for new and advanced diagnosis and treatment methods. Moreover, unique hospital infrastructures, and availability of skilled healthcare professionals is further aiding growth of the market. 

On the other hand, Asia Pacific is expected to witness significant growth in embolization particle market during the forecast period, owing to increasing patient population (mainly cancer) in emerging economies such as India. For instance, according to Indian Council Medical Research (ICMR), it is expected that over 17.3 lakh new cancer cases and over 8.8 lakh deaths will occur in India due to cancer by 2020. Moreover, growing focus by government on enhancing healthcare facilities and booming medical tourism is expected to boost growth of the embolization particle market in this region.


Embolization Particle Market – Competitive Landscape

Major players operating in the embolization particle markets include, Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., and Terumo Corporation.


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Page 1 of 61

Powered by WordPress & Theme by Anders Norén